Meyer J S, McElroy J F, Yehuda R, Miller J
Life Sci. 1984 May 14;34(20):1891-8. doi: 10.1016/0024-3205(84)90120-6.
5-Hydroxytryptophan (5-HTP) elevated serum corticosterone concentrations when administered either intraperitoneally (i.p.) or intraventricularly. Inhibition of aromatic L-amino acid decarboxylase outside of the blood-brain barrier antagonized the corticosterone response, but only when the 5-HTP was given i.p. Stimulation of the pituitary-adrenocortical system by fenfluramine was not affected by 5,7-dihydroxytryptamine pretreatment, whereas the stimulation produced by quipazine administration was blocked by lesions of the basomedial hypothalamus. These results suggest that serotonergic drugs can act at multiple sites (i.e., both central and peripheral) to evoke a pituitary-adrenocortical response.
5-羟色氨酸(5-HTP)经腹腔内(i.p.)或脑室内给药时会升高血清皮质酮浓度。在血脑屏障外抑制芳香族L-氨基酸脱羧酶可拮抗皮质酮反应,但仅在5-HTP经腹腔内给药时有效。芬氟拉明对垂体-肾上腺皮质系统的刺激不受5,7-二羟色胺预处理的影响,而喹哌嗪给药所产生的刺激则被基底内侧下丘脑损伤所阻断。这些结果表明,血清素能药物可作用于多个部位(即中枢和外周)以引发垂体-肾上腺皮质反应。